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Introduction 
 Direct compression is a straightforward, 
easiest to control, and least expensive method to 
produce tablets because of its advantage that 
possess fewer processing stages, which can 
increase the productivity and consequently 
reduce the final cost of the product [1;2]. Besides, 
with the elimination of heat and moisture effects, 
it becomes the most appropriate process for 
hygroscopic and thermo-sensitive drugs. However, 
as few drugs have the mechanical and physical 
properties that allow direct compression, 
successful tablet productions by this process is 
mainly dependent on the excipients that make 
the pharmaceutical blend [3;4]. So, the choice of 
excipients is extremely critical in formulating direct 
compression tablets. 
It is well known that traditional experimentation 
involves a good deal of effort and time, especially 
when complexes processes are evaluated. Most 
of the experiment on tablet formulation 
development is still performed in an unsystematic 
way, by changing the levels of each variable, or 
factor, at a time, and keeping all the others 
variables constant in order to study the effects of 
that specific variable on the selected response. 
Statistical experimental design is a well-established 
concept for planning and execution of 
informative experiments. In this approach, process 
variables are first “screened” to determine which 
variable is important to the outcome, and then 
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the studied experimental field. 
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follow the “optimization”, when the best settings 
for the important variables are determined [5]. 
In this way, response surface methodologies have 
been successfully applied in drug development. 
The use of experimental statistical design such as 
Central Composite Design allows to evaluate, in 
an effective and systematic way, the differences 
among the batches and makes possible to plot 
surface response graphics, which allows to 
evaluate the influence of each variable, which 
can be ranked according to its effect on the 
whole response [5;6;7;8;9].  
The aim of this work was, by using an experimental 
statistic design, to evaluate the influences of 
magnesium stearate and sodium croscarmelose 
quantities on the clozapine tablets hardness, 
friability, disintegration time and dissolution 
efficiency, by applying factorial design and 
response surface methodologies. Clozapine is a 
dibenzodiazepinic compound used in psychoses 
treatment to control schizophrenia [10]. 
 
MATERIALS AND methods 
Materials 
 The following raw materials were used: 
clozapine (Medapi Farmacêutica Ltda, Brazil), 
sodium croscarmellose (Explocel®, Blanver, Brazil), 
magnesium stearate (Henrifarma Produtos 
Químicos e Farmacêuticos Ltda, Brazil), colloidal 
silicon dioxide (Aerosil® 200, Blanver, Brazil), 
microcrystalline cellulose (Microcel® 101, Blanver, 
Brazil), and spray-dried lactose (New Zealand).  
 
Clozapine tablets preparation 
 Thirteen formulations were prepared using 
a Central Composite Design, whose experimental 
matrix is showed on Table 1. The proportions of 
magnesium stearate (STE) and sodium 
croscarmellose (SCC) were established 
empirically, according the usual concentration 
described on literature, ranging from 0.5 to 2.0 % 
to STE and 2.0 to 4.0 % to SCC. To all the 
formulations, colloidal silicon dioxide 0.5 % (w/w) 
and a mixture of microcrystalline cellulose and 
spray-dried lactose, in a proportion of 70:30 (w/w) 
were added. 
 
Table 1: Central Composite Design matrix used to 
produce clozapine tablets. 
 
Run STE (coded) SCC (coded) STE (%) SCC (%) 
1 – 1.00 – 1.00 0.50 2.00 
2 1.00 – 1.00 2.00 2.00 
3 – 1.00 1.00 0.50 4.00 
4 1.00 1.00 2.00 4.00 
5 0.00 – 1.41 1.25 1.59 
6 0.00 1.41 1.25 4.41 
7 – 1.41 0.00 0.19 3.00 
8 1.41 0.00 2.31 3.00 
9 0.00 0.00 1.25 3.00 
10 0.00 0.00 1.25 3.00 
11 0.00 0.00 1.25 3.00 
12 0.00 0.00 1.25 3.00 
13 0.00 0.00 1.25 3.00 
where : STE – magnesium stearate and SCC – 
sodium croscarmelose. 
 
 The powders were thoroughly mixed using 
an ERWEKA AR 400 mixing device (Erweka 
Apparatebau, Heusenstamm, Germany) at 20 
rpm. The tablets were produced in a rotative 
tablet press (Picolla D3 – 8, Riva®), with a 
compressional force of 15 kN. Biconcave tablets 
with a diameter of 7 mm were obtained. 
Hardness 
The hardness of tablets (n = 10) was measured 
using an Erweka TBH TAG FTCQ 003 model 
hardness tester.  
Friability 
Tablet friability was calculated as the percentage 
weight loss of 20 tablets after 100 rotations per 
minute in a Roche. J. Engelsmann (Ludwigshafen, 
Germany) friability apparatus.  
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Disintegration time 
The disintegration time was measured in purified 
water at 37 ± 1 ºC and the results represent a 
calculated average of six determinations. 
Dissolution test 
Dissolution of clozapine tablets was performed 
according to the United States Pharmacopoeia 
[11] proposed method: apparatus I (basket) at 100 
rpm, in 900 mL of pH 4.0 buffer acetate at 37 ± 1 
ºC as dissolution medium, using a Pharma Test, 
PTW S III type dissolution tester (Hamburg, 
Germany). Sink conditions were maintained 
during dissolution. Samples (n=6) were collected 
and then analyzed on a Hewlett–Packard 8452 A 
spectrophotometer (Hewlett-Packard, USA) at 290 
nm for the drug content, using the Dissolution Test 
Software vs. 03.01.  The dissolution efficiency of 
clozapine tablets, calculated by the area under 
curve, was obtained using the equation [1] 
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                                            [1] 
where ti is the ith time point, yi is the percentage of 
dissolved product at time ti. 
Experimental statistical design and statistical 
analysis 
In this study, the factors selected were amount of 
magnesium stearate (STE) and sodium 
croscarmellose (SCC). The response criteria 
evaluated were hardness, friability, disintegration 
time and dissolution efficiency of tablets. A 
preliminary evaluation of the factor levels was 
performed using a 22 factorial design without 
replication in order to define the experimental 
field. After that, the experimental design was 
transformed into a Central Composite Design, 
according Table 1. The data were adjusted to a 
polynomial second order equation by the least-
square method and the respective response 
surfaces were modeled using the results from 
Composite Central Design (StatGraphics® Plus 
version 5.1, Statistical Graphics Corp., USA). The 
model was validated statistically by ANOVA by 
means of calculation and evaluation of the 
multiple-correlation coefficients and estimation of 
the lack-of-fit, using Equation [2]: 
2
222
2
111211222110 )()(Y xxxxxx ββββββ +++++=     [2] 
where Y = response (hardness, friability, 
disintegration time, dissolution efficiency), x1 and 
x2 = equation coefficients (STE and SCC amount) 
and β0.... β 22 = regression coefficients. 
 
Results and discussion 
 Hardness, friability, disintegration time and 
dissolution efficiency of the formulation produced 
according to the central composite design are 
shown in Table 2. 
 
Table 2: Results for tablets Hardness (H), Friability 
(F), Disintegration Time (DT) and Dissolution 
Efficiency (DE). 
 
Run H F DT DE 
1 89.20 N 0.12 % 3.95 min 98.99 % 
2 64.30 N 0.31 % 3.32 min 99.57 % 
3 91.10 N 0.16 % 2.30 min 101.05 % 
4 66.50 N 0.39 % 2.05 min 101,93 % 
5 78.40 N 0.07 % 4.58 min 95.05 % 
6 70.70 N 0.31 % 2.02 min 101.71 % 
7 87.50 N 0.06 % 3.02 min 100.89 % 
8 62.30 N 0.26 % 2.71 min 101.37 % 
9 64.40 N 0.10 % 2.75 min 98.91 % 
10 59.10 N 0.10 % 2.75 min 98.91 % 
11 67.00 N 0.25 % 2.7 min 100.16 % 
12 60.60 N 0.11 % 3.12 min 100.15 % 
13 65.30 N 0.20 % 3.07 min 99.57 % 
 
 The results from Table 2 were used to fit an 
appropriated second order model from each 
dependent variable and the general equation 
was adjusted by a non-linear regression to the STE 
and SCC factors, allowing the determination of 
constant, linear, quadratic and interaction terms. 
P
a
g
e
 3
3
5
 
F
u
ll L
en
g
th
 O
rig
in
a
l R
esea
rch
 P
a
p
er 
Covered in Scopus & Embase, Elsevier                                             Int. J. Drug Dev. & Res., July-September 2013, 5 (3): 333-340 
© 2013 Tiago Rafael Sausen et al, publisher and licensee IYPF. This is an Open Access article which permits unrestricted 
noncommercial use, provided the original work is properly cited.
The mathematical model that describes the 
hardness was: 
[ ]3     SCC6.407STE11.645SCCSTE0.0984SCC39.414-STE43.603-159.831H  22 ×+×+××+×= ×
where H = hardness; STE = STE factor; SCC = SCC 
factor; STESCC = factor interaction 
The results from the multiple regression 
coefficient calculated from equation 3 indicated 
that about 93 % of the experimental variance 
could be explained (r2 = 0.927). Once the lack-of-
fit test was not significant (F(P 0.95; FG 3.4) = 6.59 > 
2.18), the experimental variation could be 
ascribed to a randomized error that was not 
related to the experimental model. Thus, the 
regression model expressed by equation 3 
appears to be satisfactory to describe the tablet 
hardness behavior. 
 Considering the ANOVA and the t-test 
results (Table 3), with the exception of the 
interaction between the STE and the SCC factors, 
the linear and quadratic coefficients had a 
significant effect on the estimated response. The 
STE quadratic term had the higher effect on the 
tablet hardness, followed by the SCC quadratic 
term, and both showed a positive effect (hardness 
increase). The STE and SCC linear terms were also 
significant, showing a negative effect on the 
tablet hardness. 
 
Table 3: Results of the t-test for equation 3 
coefficients 
 
Term Coefficient Standard Error t calculated 
1 159.831 17.665 9.048 
STE – 43.603 10.675 4.085* 
SCC – 39.414 9.870 3.993* 
Interaction  0.0984 2.677 0.0367 
STE2 11.645 2.709 4.299* 
SCC2 6.407 1.529 4.190* 
* significant for α = 0.95 
 
The response surface (Figure 1a) and the 
corresponding contour-plot (Figure 1b) graphs 
showed that tablet hardness was almost 
independent of the SCC concentration, but an 
increase in the STE concentration caused a 
decreased in tablet hardness. When the SCC 
concentration were lower than 2.5 % and higher 
than 3.5 %, a slight increase in tablet hardness, 
was observed on the experimental field. 
 
Figure 1: Response surface (a) and contour-plot 
graphic (b) calculated to the tablet hardness 
according to equation 3. 
 
To the friability parameter F, the equation 
[4] was obtained: 
[ ]4     SCC0.0368STE0.0382SCCSTE0.0133SCC0.180-STE0.0185-0.274F  22 ×+×+××+××=
where F = friability; STE = STE factor; SCC = SCC 
factor; STESCC = factor interaction 
 
The results from the ANOVA test were not 
significant (P > 0.05), so the equation 4 was not 
satisfactory to describe the tablet friability 
behavior. The lower multiple regression coefficient 
value (r2 = 0.728) showed that the equation is 
adequate, but the mathematical model 
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proposed was not able to differ the obtained 
response (friability) and the graphic background 
noise. As the results from the t-test showed that the 
proposed model was not satisfactory either, 
(coefficients not significant – P > 0.05), the 
response surface and the contour-plot graphics 
could not be plotted. 
 
Table 4: Results of the t-test for equation 4 
coefficients 
 
Term Coefficient Standard Error t calculated 
1 0.274 0.321 0.854 
STE – 0.0185 0.194 0.0952 
SCC – 0.180 0.179 1.005 
Interaction  0.0133 0.0486 0.275 
STE2 0.0382 0.0492 0.778 
SCC2 0.0368 0.0278 1.325 
 
It can be observed that the hardness and 
friability were more susceptible to the STE 
concentration, and that this excipient caused a 
decreased in the tablet mechanical resistance. 
The formulations with lower STE concentration 
produced tablets with higher hardness and lower 
friability. As the lubricant particles cover the 
formulation components surface, they act as a 
mechanical barrier, interfering on the mixture 
binding properties and consequently producing 
tablets mechanically weaker [12;13]. 
 The following mathematical model was 
estimated to the disintegration time, according 
the central composite design, resulting the 
equation [5]: 
[ ]5     SCC0.123STE0.169SCCSTE0.127SCC1.714-STE0.716-7.013DT  22 ×+×+××+××=  
where DT = disintegration time; STE = STE factor; 
SCC = SCC factor; STESCC = factor interaction 
The equation 5 shows that about 95 % of 
experimental variance could be explained by the 
multiple regression coefficient calculated (r2 = 
0.953). As the lack-of-fit test was not significant (F (P 
0.95; FG 3.4) = 6.59 > 1.43), a possible experimental 
variation could be ascribed to a randomized error 
that was not related to the experimental model, 
and the regression model expressed by equation 
5 seems to be satisfactory to describe the 
disintegration time behavior of these tablets. 
According to Table 5, it was possible to assume 
that the mathematical model proposed to explain 
the tablet disintegration time behavior was 
adequate, and the experimental variance could 
be attributed to a randomized error that was not 
related to the experimental model. 
 
Table 5: Results of the t-test for equation 5 
coefficients 
 
Term Coefficient Standard Error t calculated 
1 7.120 0.937 7.599 
STE – 0.135 0.529 0.256 
SCC – 1.824 0.559 3.264* 
Interaction  0.119 0.117 1.019 
STE2 – 0.178 0.139 1.239 
SCC2 0.146 0.0847 1.592 
* significant for α = 0.95 
 
The results from the t-test (Table 5) showed that 
the disintegration time was only influenced by 
SCC concentration, where the SCC lineal term 
was the main responsible for the decrease in the 
tablets disintegration time. All the others equations 
components had no statistical significance on the 
response. The response surface (Figure 2a) and 
the contour-plot graphics (Figure 2b) showed that 
the disintegration time decreased when higher 
SCC concentrations are combined with higher STE 
concentrations. It can be observed that the lower 
disintegration time was obtained when the SCC 
concentration was higher than 3.5 % and the STE 
concentration was higher than 2.0 %. 
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 Figure 2: Response surface (a) and contour-plot 
graphic (b) calculated to the tablet disintegration 
time according to equation 5. 
 
Tablets containing higher SCC concentrations 
showed lower disintegration time. The decrease in 
the disintegration time observed when the SCC 
concentration increase was also verified in early 
works [14;15;16], which proves the high efficiency of 
the disintegrant used in the production of tablets 
by direct compression. As the STE is a hygroscopic 
excipient, one expected that its presence would 
result in an increase in the disintegration time of 
tablets. However, in the studied experimental 
field, STE presented an unexpected effect, 
therefore reducing the disintegration time when its 
concentration was increased, demonstrating an 
anomalous behavior of the STE considering the 
disintegration time. 
Equation [6] was fitted to the dissolution efficiency 
parameter, DE: 
[ ]6     SCC0.427STE1.691SCCSTE0.998SCC4.168STE4.171-93.080DE  22 ×−×+××+×+×=
where: DE = dissolution efficiency; STE = STE factor; 
SCC = SCC factor; STESCC = factor interaction. 
The analysis of the regression indicates that 
equation 6 was valid to describe the tablets 
dissolution efficiency (r2 = 0.856) and the 
experimental variance can be attributed to the 
pure experimental error and does not depend on 
the adjustment model to the experimental data (F 
(P 0.95; FG 3.4) = 6.59 > 3.70). The results of the t-test for 
the equation coefficients (Table 6) demonstrate 
that the dissolution efficiency were influenced by 
the quadratic component of the STE 
concentration, followed by the linear component 
of the SCC concentration. All the others 
coefficients had no statistical significance on the 
dissolution efficiency. 
 
Table 6: Results of the t-test for equation 6 
coefficients 
 
Term Coefficient Standard Error t calculated 
1 93.080 3.912 23.792 
STE – 4.171 2.364 1.764 
SCC 4.618 2.186 1.907* 
Interaction  0.0998 0.593 0.168 
STE2 1.691 0.600 2.819* 
SCC2 – 0.427 0.339 1.260 
* significant for α = 0.95 
 
The response surface (Figure 3a) and the contour-
plot graphic (Figure 3b) showed that the 
dissolution efficiency was mainly affected by SCC 
concentration, where an increase in the SCC 
concentration caused a faster disintegration and 
higher tablet dissolution efficiency. The increase in 
the STE concentration did not change the 
dissolution efficiency, however, when the STE 
concentration was higher than 2 %, an increase in 
the tablet dissolution efficiency was observed. The 
higher the SCC proportion, the faster the tablet 
disintegration and thereof the clozapine release. 
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 Figure 3: Response surface (a) and contour-plot 
graphic (b) calculated to the tablet dissolution 
efficiency according to equation 6. 
 
The STE effect was best observed on the 
dissolution efficiency than on the disintegration 
time, strengthening the STE anomalous behavior 
upon the disintegration time. According to the 
surface response (Figure 3), an increase in STE 
concentration cause a decrease in the 
disintegration time, however, this increase does 
not reduce the dissolution efficiency values in the 
same extent. 
 
CONCLUSIONS 
As the development of pharmaceutical 
products involves effort and time, a very efficient 
way to enhance the value of research, to 
minimize the process development time and 
obtain information concerning the influence of 
the different excipients is through designed 
experiments. Using experimental design, such as 
Central Composite Design, where a given number 
of experiments are selected out of many possible 
ones, is a good way in order to obtain a 
statistically optimized design.  
According the Central Composite Design 
proposed for this work, the STE concentration 
influenced the tablet mechanical resistance, 
affecting the hardness in a negative way, 
decreasing the obtained values, and the friability 
in a positive way, increasing the obtained values. 
The SCC proportion determined a linear decrease 
in the disintegration time, causing a faster 
clozapine release from the tablets, thereby 
increasing tablets dissolution efficiency. It was 
possible to verify a STE anomalous behavior, 
because the increase on its amount results in a 
decrease in disintegration time. However, this 
increase does not cause an increase on the tablet 
dissolution efficiency, on the experimental field. 
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